Azacitidine Nanoemulsion Formulation and Characterization for the Tumor Treatment Suppressor Genes Activity in Myeloid Leukemia Cell Lines. AJP [Internet]. 2025 Sep. 30 [cited 2026 Apr. 14];19(3). Available from: http://www.asiapharmaceutics.info/index.php/ajp/article/view/6820